欢迎访问行业研究报告数据库

行业分类

当前位置:首页 > 报告详细信息

找到报告 1 篇 当前为第 1 页 共 1

卵巢癌的靶向紫杉醇纳米粒

Targeting Paclitaxel-Loaded Nanoparticles to Ovarian Cancer

作者:Howell, S. B. 加工时间:2015-08-25 信息来源:科技报告(AD) 索取原文[24 页]
关键词:纳米颗粒;卵巢;肿瘤细胞(生物学)
摘 要:The specific aims of this project are to: 1) determine the efficacy, pharmacokinetics, toxicology and imaging capacity of RGDtargeted Nexil; and, 2) determine the ability of other ovarian cancer-specific targeting ligands to enhance the efficacy of Nexil. Substantial progress has been made on both of these specific aims. This is the final report. We have established that there is an excellent correlation between the tumor uptake of Nexil and its ability to deliver paclitaxel in a panel of 8 human tumor xenografts. Although we successfully synthesized RGD-target Nexil we were unable to show improved efficacy in a lung cancer mode. We have shown that the CPE peptide effectively targets the toxin gelonin to human ovarian cancer cells in a claudindependent manner, but that this fusion molecule has a difficult time getting out of the endosomal compartment and reaching the ribosome which is the target of gelonin. We have identified the A6 peptide as a CD44 tumor-targeting peptide worthy of further study.
© 2016 武汉世讯达文化传播有限责任公司 版权所有 技术支持:武汉中网维优
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服